Literature DB >> 24151319

BLT humanized mice as model to study HIV vaginal transmission.

Maud Deruaz1, Andrew D Luster.   

Abstract

The majority of human immunodeficiency virus type 1 (HIV-1) infections occur by sexual exposure, and vaginal transmission accounts for more than half of all newly acquired infections. Studies of vaginal transmission of simian immunodeficiency virus to nonhuman primates (NHPs) have suggested an important role for immune cell trafficking in the establishment of infection as well is in the process of viral dissemination. However, NHP models do not permit the study of HIV transmission and dissemination. The improvement of humanized mouse models with robust human immune cell reconstitution of the female genital tract renders these mice susceptible to intravaginal HIV infection. Thus humanized mouse models of HIV vaginal infection will allow the study of the mechanisms involved in HIV transmission and dissemination in vivo.

Entities:  

Keywords:  HIV; humanized mice; mucosal infection

Mesh:

Year:  2013        PMID: 24151319      PMCID: PMC3807970          DOI: 10.1093/infdis/jit318

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  48 in total

1.  Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.

Authors:  T W Chun; R T Davey; M Ostrowski; J Shawn Justement; D Engel; J I Mullins; A S Fauci
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

Review 2.  Target cells in vaginal HIV transmission.

Authors:  Christopher J Miller; Robin J Shattock
Journal:  Microbes Infect       Date:  2003-01       Impact factor: 2.700

3.  Antimicrobial components of vaginal fluid.

Authors:  Erika V Valore; Christina H Park; Sorina L Igreti; Tomas Ganz
Journal:  Am J Obstet Gynecol       Date:  2002-09       Impact factor: 8.661

4.  Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells.

Authors:  Z Zhang; T Schuler; M Zupancic; S Wietgrefe; K A Staskus; K A Reimann; T A Reinhart; M Rogan; W Cavert; C J Miller; R S Veazey; D Notermans; S Little; S A Danner; D D Richman; D Havlir; J Wong; H L Jordan; T W Schacker; P Racz; K Tenner-Racz; N L Letvin; S Wolinsky; A T Haase
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

5.  Sodium dodecyl sulfate and C31G as microbicidal alternatives to nonoxynol 9: comparative sensitivity of primary human vaginal keratinocytes.

Authors:  F C Krebs; S R Miller; B J Catalone; P A Welsh; D Malamud; M K Howett; B Wigdahl
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

6.  Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use.

Authors:  Beens Varghese; Julie E Maher; Thomas A Peterman; Bernard M Branson; Richard W Steketee
Journal:  Sex Transm Dis       Date:  2002-01       Impact factor: 2.830

7.  Higher levels of activation markers and chemokine receptors on T lymphocytes in the cervix than peripheral blood of normal healthy women.

Authors:  M Prakash; M S Kapembwa; F Gotch; S Patterson
Journal:  J Reprod Immunol       Date:  2001 Oct-Nov       Impact factor: 4.054

8.  Memory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system.

Authors:  Phalguni Gupta; Kelly B Collins; Deena Ratner; Simon Watkins; Gregory J Naus; Daniel V Landers; Bruce K Patterson
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection.

Authors:  Eberhard W Fiebig; David J Wright; Bhupat D Rawal; Patricia E Garrett; Richard T Schumacher; Lorraine Peddada; Charles Heldebrant; Richard Smith; Andrew Conrad; Steven H Kleinman; Michael P Busch
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

10.  Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1.

Authors:  Richard E Haaland; Paulina A Hawkins; Jesus Salazar-Gonzalez; Amber Johnson; Amanda Tichacek; Etienne Karita; Olivier Manigart; Joseph Mulenga; Brandon F Keele; George M Shaw; Beatrice H Hahn; Susan A Allen; Cynthia A Derdeyn; Eric Hunter
Journal:  PLoS Pathog       Date:  2009-01-23       Impact factor: 6.823

View more
  17 in total

1.  Alcohol consumption increases susceptibility to pneumococcal pneumonia in a humanized murine HIV model mediated by intestinal dysbiosis.

Authors:  Derrick R Samuelson; Robert W Siggins; Sanbao Ruan; Angela M Amedee; Jiusong Sun; Quan Karen Zhu; Wayne A Marasco; Christopher M Taylor; Meng Luo; David A Welsh; Judd E Shellito
Journal:  Alcohol       Date:  2018-09-11       Impact factor: 2.405

2.  Chemoattractant-mediated leukocyte trafficking enables HIV dissemination from the genital mucosa.

Authors:  Maud Deruaz; Thomas T Murooka; Sophina Ji; Marc A Gavin; Vladimir D Vrbanac; Judy Lieberman; Andrew M Tager; Thorsten R Mempel; Andrew D Luster
Journal:  JCI Insight       Date:  2017-04-06

3.  VRC01 antibody protects against vaginal and rectal transmission of human immunodeficiency virus 1 in hu-BLT mice.

Authors:  Ming Sun; Yue Li; Zhe Yuan; Wuxun Lu; Guobin Kang; Wenjin Fan; Qingsheng Li
Journal:  Arch Virol       Date:  2016-06-24       Impact factor: 2.574

4.  Recent advances in humanized mice: accelerating the development of an HIV vaccine.

Authors:  Andrew M Tager; Michael Pensiero; Todd M Allen
Journal:  J Infect Dis       Date:  2013-11       Impact factor: 5.226

Review 5.  BLT humanized mice as a small animal model of HIV infection.

Authors:  Marshall E Karpel; Christian L Boutwell; Todd M Allen
Journal:  Curr Opin Virol       Date:  2015-06-12       Impact factor: 7.090

6.  Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "Meet the Experts" 2015 Workshop Summary.

Authors:  Ramesh Akkina; Atef Allam; Alejandro B Balazs; Joel N Blankson; John C Burnett; Sofia Casares; J Victor Garcia; Kim J Hasenkrug; Fatah Kashanchi; Scott G Kitchen; Florian Klein; Priti Kumar; Andrew D Luster; Larisa Y Poluektova; Mangala Rao; Brigitte E Sanders-Beer; Leonard D Shultz; Jerome A Zack
Journal:  AIDS Res Hum Retroviruses       Date:  2016-02       Impact factor: 2.205

7.  A participant-derived xenograft model of HIV enables long-term evaluation of autologous immunotherapies.

Authors:  Chase D McCann; Christiaan H van Dorp; Ali Danesh; Adam R Ward; Thomas R Dilling; Talia M Mota; Elizabeth Zale; Eva M Stevenson; Shabnum Patel; Chanson J Brumme; Winnie Dong; Douglas S Jones; Thomas L Andresen; Bruce D Walker; Zabrina L Brumme; Catherine M Bollard; Alan S Perelson; Darrell J Irvine; R Brad Jones
Journal:  J Exp Med       Date:  2021-05-14       Impact factor: 14.307

Review 8.  Baseline and time-updated factors in preclinical development of anionic dendrimers as successful anti-HIV-1 vaginal microbicides.

Authors:  Ignacio Rodríguez-Izquierdo; Daniel Sepúlveda-Crespo; Jose María Lasso; Salvador Resino; Ma Ángeles Muñoz-Fernández
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2022-01-12

9.  Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission.

Authors:  Martina Kovarova; Olivia D Council; Abhijit A Date; Julie M Long; Tomonori Nochi; Tomonori Nochii; Michael Belshan; Annemarie Shibata; Heather Vincent; Caroline E Baker; William O Thayer; Guenter Kraus; Sophie Lachaud-Durand; Peter Williams; Christopher J Destache; J Victor Garcia
Journal:  PLoS Pathog       Date:  2015-08-13       Impact factor: 6.823

Review 10.  Humanized Mice for Infectious and Neurodegenerative disorders.

Authors:  Prasanta K Dash; Santhi Gorantla; Larisa Poluektova; Mahmudul Hasan; Emiko Waight; Chen Zhang; Milica Markovic; Benson Edagwa; Jatin Machhi; Katherine E Olson; Xinglong Wang; R Lee Mosley; Bhavesh Kevadiya; Howard E Gendelman
Journal:  Retrovirology       Date:  2021-06-05       Impact factor: 3.768

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.